Security · CUSIP 15089R102
CELATOR PHARMACEUTICALS INC
COM · institutional ownership from 13F filings
13F holders
6
Shares held
3.2M
Value held
$10.4M
New / sold out
5 / 0
Added / reduced
0 / 0
net +2.9M shares
13F holders by quarter
Net shares bought by existing holders
Top holders · Q4 2013
| Manager | Shares | Value | % of portfolio |
|---|---|---|---|
| CAXTON CORP | 2,246,469 | $7.3M | 4.64% |
| SABBY MANAGEMENT, LLC | 679,592 | $2.2M | 1.06% |
| Opaleye Management Inc. | 310,000 | $961.0K | 0.75% |
| BANK OF AMERICA CORP /DE/ | 467 | $2.0K | 0.00% |
| Tower Research Capital LLC | 540 | $2.0K | 0.00% |
| UBS AG | 160 | $1.0K | 0.00% |
Biggest buyers
| Manager | Change | Shares change | Change % |
|---|---|---|---|
| CAXTON CORP | New | +2,246,469 | – |
| SABBY MANAGEMENT, LLC | New | +679,592 | – |
| Tower Research Capital LLC | New | +540 | – |
| BANK OF AMERICA CORP /DE/ | New | +467 | – |
| UBS AG | New | +160 | – |
Biggest sellers
Nothing to show.